<DOC>
	<DOCNO>NCT00202410</DOCNO>
	<brief_summary>The frequency auto-immune disease ( include multiple sclerosis ) increase industrialised country . According hypothesis receiving wide international credit , may due fact population country increasingly less exposed microbe improvement hygienic condition use antibiotic . If exposure microbe lacking , also regulatory function miss consequent possible onset auto-immune symptom . For reason , deem expose immune system patient ancient microbe , complex important man evolution , like Tuberculosis Mycobacterium , possible rebalance immune system .</brief_summary>
	<brief_title>Efficacy Anti-Tubercular Vaccination Multiple Sclerosis</brief_title>
	<detailed_description>Vaccination Tuberculosis Mycobacterium prove effective animal model multiple sclerosis , experimental allergic encephalitis . In study phase I-II group demonstrate safety therapy together preliminary evidence . The study include patient initial disease ( diagnosis support paraclinical criterion ) : single clinical poly mono-symptomatic attack 6 month precede study , MR picture compatible MS. Study design 100 randomized patient ( i.e . randomly assign ) include either group 50 patient undergoing therapy group 50 patient receive placebo . Patients follow monthly contrast MRI 6 month . At end six month disease activity group treat patient benchmarked disease activity group patient receive placebo . Safety grant extremely wide diffusion kind vaccination worldwide previous study patient affect multiple sclerosis .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antitubercular Agents</mesh_term>
	<criteria>Patients initial disease ( diagnosis support paraclinical criterion ) : single clinical poly monosymptomatic attack 6 month precede study , MR picture compatible MS Therapy corticosteroid last month Plasmapheresis , administration gamma globulin last three month Serious heart , renal , hepatic haematological dysfunction define laboratory exams Evidence infection Evidence tubercular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Tuberculosis vaccine</keyword>
	<keyword>Therapy</keyword>
</DOC>